Your browser doesn't support javascript.
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents.
Silvestris, Nicola; Munafò, Antonio; Brunetti, Oronzo; Burgaletto, Chiara; Scucces, Luisa; Bernardini, Renato.
  • Silvestris N; Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Munafò A; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Brunetti O; Section on Pharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania School of Medicine, Catania, Italy.
  • Burgaletto C; Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Scucces L; Section on Pharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania School of Medicine, Catania, Italy.
  • Bernardini R; Section on Pharmacology, Department of Biomedical and Biotechnological Sciences, University of Catania School of Medicine, Catania, Italy.
Front Oncol ; 10: 1340, 2020.
Article in English | MEDLINE | ID: covidwho-707140

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Oncol Year: 2020 Document Type: Article Affiliation country: Fonc.2020.01340

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Oncol Year: 2020 Document Type: Article Affiliation country: Fonc.2020.01340